Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging Cover

.blurhash-client-img { display: none !important; }

Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging

Acta Pharmaceutica

Volume 59 (2009): Issue 1 (March 2009)

By: Amir Jalilian, Nima Rostampour, Pejman Rowshanfarzad, Kamaleddin Shafaii, Mohsen Kamali-Dehghan and Mehdi Akhlaghi

Open Access

|Mar 2009

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/v10007-009-0008-9 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 45 - 55

Published on: Mar 20, 2009

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

radiopharmaceuticals,

[⁶¹Cu]ATSM hypoxia,

positron emission tomography,

Related subjects:

Pharmacy, other

© 2009 Amir Jalilian, Nima Rostampour, Pejman Rowshanfarzad, Kamaleddin Shafaii, Mohsen Kamali-Dehghan, Mehdi Akhlaghi, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 59 (2009): Issue 1 (March 2009)